Vaccitech Newsroom

Vaccitech will progress existing vaccine programs and the collaboration will combine Vaccitech’s know-how with GeneMatrix’s clinical network. Oxford, UK and Seoul, South Korea Vaccitech, a clinical stage developer of a universal flu vaccine and other vaccine-related...

The role of the Research Associate will be to conduct and assist in the evaluation of new processes in viral vectored vaccine production. The research associate will also help to improve existing processes to improve efficiency and quality. They will ensure that all...

The role of the senior scientist will be to design, conduct, optimize and evaluate new processes in viral vector production. The senior scientist will also work to improve existing process design to improve efficiency and quality. They will monitor the field for new...

Vaccitech Ltd is seeking a molecular biologist to join a team focused on viral vectored vaccines research and development. The successful candidate will play a critical role in the development of new approaches to generate viral vaccine vectors, including (but not...

Vaccitech Ltd is seeking a senior scientist with experience in analytics to join a team focused on viral vectored vaccines research and development. The successful candidate will perform existing quality control assays as well as play a critical role in the...

Vaccitech Ltd is seeking a Research Associate with experience in analytics to join a team focused on viral vectored vaccines research and development. The successful candidate will play an integral role in conducting bench studies to support vector production and...

Vaccitech has taken the decision not to proceed with season 2 of the current FLU007 (Invictus) study due to the changes recommended by the UK Government which directed the NHS to use FLUAD (adjuvanted TIV) vaccine in the 65 year old and over population in the 2018/19...

CEPI Awards Contract Worth Up To USD$19 million to Oxford University and Janssen Vaccines to Develop MERS, Lassa, and Nipah Vaccines   Posted on http://cepi.net/node/425 27th September 2018 by Mario Christodoulou   OSLO (Norway), Oxford (UK) CEPI (the Coalition for...

Vaccitech will combine Oxford University vaccine know-how with the manufacturing expertise of China’s CanSino Biologics in collaboration focused on herpes zoster. Vaccitech Limited, a UK-based company developing products to treat and prevent multiple infectious...

View/Download ASCO 2018...